| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Metalloproteinase inhibitor 1|Erythroid-potentiating activity|EPA|Fibroblast collagenase inhibitor|Collagenase inhibitor|Tissue inhibitor of metalloproteinases 1|TIMP-1|TIMP1|CLGI|TIMP |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target | |
| UniProt # |
Background
human TIMP-1 (Metalloproteinase inhibitor 1) is a molecular target commonly studied in immunology, signal transduction, and cardiovascular research. Many proteins are studied as molecular readouts that can change with cellular state, tissue remodeling, or stress responses.
Biological role and mechanism
The biological role of TIMP-1 is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of TIMP-1 can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
TIMP-1 (Metalloproteinase inhibitor 1) may also be referenced as Metalloproteinase inhibitor 1, Erythroid-potentiating activity, and EPA in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how TIMP-1 relates to innate and adaptive immune responses, cytokine signaling networks, host–pathogen interactions, and immune cell activation and trafficking in immunology, signal transduction, and cardiovascular research.
- Interpreting shifts in TIMP-1 levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
TIMP-1 has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with immunology, signal transduction, and cardiovascular studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
SERPINA3: A novel inflammatory biomarker associated with cerebral small vessel disease burden in ischemic stroke
IF: 5.5 Journal: CNS Neuroscience & Therapeutics Author: Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China Cited Date: 2023-09-28
The effects of Vitamin D on Keratoconus progression
IF: 4.2 Journal: American Journal of Ophthalmology Author: From the Eye Repair Unit, Division of Neuroscience (N.B., S.P., P.F., G.S., G.T., and G.F.), IRCCS San Raffaele Scientific Institute, Milan, Italy. Cited Date: 2025-10-17
24-month decline of non-invasive liver fibrosis markers in HCV-mono and HCV/HIV coinfection after direct-acting antiviral therapy
IF: 3.998 Journal: Scientific Reports Cited Date: 2022-03-17
Vitamin D Supplementation Impacts Systemic Biomarkers of Collagen Degradation and Copper Metabolism in Patients With Keratoconus
IF: 3.048 Journal: Translational Vision Science & Technology Cited Date: 2023-01-06
THE IMPACT OF OBSTRUCTIVE SLEEP APNEA/HYPOPNEA SYNDROME ON THE LEVELS OF TISSUE INHIBITOR OF MATRIX METALLOPROTEINASE-1 AND HYPOXIA-INDUCIBLE FACTOR-1Α IN ATRIAL FIBRILLATION PATIENTS
IF: Journal: Journal of the Grodno State Medical University Cited Date: 2020-09-30
Photoaging and Fibroblasts: The Role of a Novel Dermal Fibroblast Population in Tissue Regeneration and the Response to Solar Radiation
IF: Journal: Düsseldorf Document- and Publishingservice Cited Date: 2022-11-24
The role of Matrix metalloproteinase (MMP-9) and its tissue inhibitor (TIMP1) in Cutaneous Leishmaniasis patients and their role in prognosis
IF: Journal: Iraqi Journal of Science Author: Department. of Biology, College of Science, University of Baghdad, Al-Jaderiya Campus, Baghdad, Iraq 10071 Cited Date: 2025-08-22
Clinical Sensitivity of Platelet Index and Their Association with Matrix Metalloproteinase 2 and 9: A Diagnostic Approach in Preeclampsia
IF: Journal: Foundry Journal Author: Department of Biochemistry, Mahatma Gandhi Medical College & Research Institute, Sri Balaji Vidyapeeth (Deemed to be University), Pondicherry, India. Cited Date: 2024-10-25
Plasma TIMP-1 is a Useful Tool for Monitoring 24 Months Liver Fibrosis Improvement After Anti-HCV/DAA Therapy in HCV/HIV Mono/Coinfection
IF: Journal: Research Square Cited Date: 2021-09-09